ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1315

Japanese Relapsing Polychondritis Patients with Airway Involvement Were Mutually Exclusive with Those with Ear Involvement in the Clinical Characteristics

Jun Shimizu1 and Noboru Suzuki2, 1Department of Immunology and Medicine, St. Marianna University School of Medicine, Kawasaki, Japan, 2Department of Immunology and medicine, St. Marianna University School of Medicine, Kawasaki-shi, 216-8511, Japan

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Epidemiologic methods and polychondritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Miscellaneous Rheumatic and Inflammatory Diseases Poster II: Interstitial Lung Disease, Still's Disease, FMF, Polychondritis

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Relapsing polychondritis (RP) is a multisystem disorder of cartilaginous tissues. We previously found that, in a Japanese cohort study, RP patients with airway involvement and RP patients with external ear involvement were mutually exclusive in the clinical characteristics, suggesting an inverse relationship between airway involvement and ear involvement (Arthritis Rheumatol. 2018; 70: 148–9.). Here, we divided the patients into two subgroups by the patterns of clinical manifestations, namely a subgroup of patients with airway involvement (A subgroup) and those with ear involvement (E subgroup) and investigated the clinical and laboratory characteristics of each subgroup.

Methods: After categorizing 239 Japanese patients into two (A and E) subgroups, we compared patients’ profiles, clinical features, laboratory findings, medicines, and prognosis using dummy variables and the Student’s t-test. The presence and absence of these clinical and laboratory parameters formed dummy variables, 1 and 0, respectively. We measured serum matrix metalloproteinase-3 (MMP3) concentrations and anti-type II collagen antibody titers, disease-related biomarkers, of 26 samples obtained from 22 newly recruited RP patients.

Results: In Japanese RP patients, 47 patients (19.7%) and 118 patients (49.4%) were allocated to the A and E subgroups, respectively. In a comparison of the clinical data between the two subgroups, saddle nose deformity and progressive disease course were observed frequently in the A subgroup. Joint, eye, and CNS involvement were observed frequently in the E subgroup. The remaining RP patients formed the third subgroup (75 patients, 31.4%) and had both airway and ear involvement (termed as B subgroup). Disease duration of the B subgroup (5.70 ± 0.64 years) was significantly longer than that of the E subgroup (4.12 ± 0.45 years). We found that cardiovascular involvement was more predominant in the B subgroup than in the A and E subgroups. High concentrations of serum MMP3 were observed frequently in the B subgroup compared with A and E subgroups. In a new cohort of 26 serum samples, MMP3 concentrations were significantly higher in the B subgroup (n=10) than those in the A subgroup (n=6) and E subgroup (n=10).

Conclusion: RP patients in the A and E subgroups exhibited different characteristics from each other. Progressive disease course and CNS involvement were observed frequently in the A and E subgroups, respectively, in Japanese patients with RP. We did not observed cardiovascular involvement in the A subgroup of the RP patients.


Disclosure: J. Shimizu, None; N. Suzuki, None.

To cite this abstract in AMA style:

Shimizu J, Suzuki N. Japanese Relapsing Polychondritis Patients with Airway Involvement Were Mutually Exclusive with Those with Ear Involvement in the Clinical Characteristics [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/japanese-relapsing-polychondritis-patients-with-airway-involvement-were-mutually-exclusive-with-those-with-ear-involvement-in-the-clinical-characteristics/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/japanese-relapsing-polychondritis-patients-with-airway-involvement-were-mutually-exclusive-with-those-with-ear-involvement-in-the-clinical-characteristics/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology